Market closed

Omega Therapeutics/OMGA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Omega Therapeutics

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.

Ticker

OMGA
Trading on

Industry

Biotechnology

Employees

94

OMGA Metrics

BasicAdvanced
$55M
Market cap
-
P/E ratio
-$1.43
EPS
1.86
Beta
-
Dividend rate
$55M
1.86
$6.30
$0.99
165K
2.195
1.825
423.125
483.394
-44.77%
-25.37%
-129.15%
8.633
2.08
2.08
-0.809
142.47%
-35.41%
-49.43%

What the Analysts think about OMGA

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Omega Therapeutics stock.

OMGA Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

OMGA Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy OMGA

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Omega Therapeutics stock?

Omega Therapeutics (OMGA) has a market cap of $55M as of October 12, 2024.

What is the P/E ratio for Omega Therapeutics stock?

The price to earnings (P/E) ratio for Omega Therapeutics (OMGA) stock is 0 as of October 12, 2024.

Does Omega Therapeutics stock pay dividends?

No, Omega Therapeutics (OMGA) stock does not pay dividends to its shareholders as of October 12, 2024.

When is the next Omega Therapeutics dividend payment date?

Omega Therapeutics (OMGA) stock does not pay dividends to its shareholders.

What is the beta indicator for Omega Therapeutics?

Omega Therapeutics (OMGA) has a beta rating of 1.86. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.